|
Granger, Meaghan; Grupp, Stephan A; Kletzel, Morris et al. (2012) Feasibility of a tandem autologous peripheral blood stem cell transplant regimen for high risk neuroblastoma in a cooperative group setting: a Pediatric Oncology Group study: a report from the Children's Oncology Group. Pediatr Blood Cancer 59:902-7
|
|
Geller, James I; Wall, Donna; Perentesis, John et al. (2009) Phase I study of paclitaxel with standard dose ifosfamide in children with refractory solid tumors: a Pediatric Oncology Group study (POG 9376). Pediatr Blood Cancer 52:346-50
|
|
Thompson, Patrick A; Gupta, Manish; Rosner, Gary L et al. (2008) Pharmacokinetics of irinotecan and its metabolites in pediatric cancer patients: a report from the children's oncology group. Cancer Chemother Pharmacol 62:1027-37
|
|
Horton, Terzah M; Blaney, Susan M; Langevin, Anne-Marie et al. (2005) Phase I trial and pharmacokinetic study of raltitrexed in children with recurrent or refractory leukemia: a pediatric oncology group study. Clin Cancer Res 11:1884-9
|
|
Hayashi, Robert J; Blaney, Susan; Sullivan, Jim et al. (2003) Phase 1 study of Paclitaxel administered twice weekly to children with refractory solid tumors: a pediatric oncology group study. J Pediatr Hematol Oncol 25:539-42
|
|
Blaney, S; Berg, S L; Pratt, C et al. (2001) A phase I study of irinotecan in pediatric patients: a pediatric oncology group study. Clin Cancer Res 7:32-7
|
|
Riva, L; Blaney, S M; Dauser, R et al. (2000) Pharmacokinetics and cerebrospinal fluid penetration of CI-994 (N-acetyldinaline) in the nonhuman primate. Clin Cancer Res 6:994-7
|
|
Tubergen, D G; Stewart, C F; Pratt, C B et al. (1996) Phase I trial and pharmacokinetic (PK) and pharmacodynamics (PD) study of topotecan using a five-day course in children with refractory solid tumors: a pediatric oncology group study. J Pediatr Hematol Oncol 18:352-61
|
